Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial

IMPORTANCE: Efficacy of cannabidiol has been demonstrated in seizures associated with Lennox-Gastaut and Dravet syndromes but appears not yet to have been established in conditions with primarily focal seizures, such as tuberous sclerosis complex (TSC). OBJECTIVE: To evaluate efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Elizabeth A., Bebin, E. Martina, Bhathal, Hari, Jansen, Floor E., Kotulska, Katarzyna, Lawson, John A., O'Callaghan, Finbar J., Wong, Michael, Sahebkar, Farhad, Checketts, Daniel, Knappertz, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754080/
https://www.ncbi.nlm.nih.gov/pubmed/33346789
http://dx.doi.org/10.1001/jamaneurol.2020.4607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754080/
https://www.ncbi.nlm.nih.gov/pubmed/33346789
http://dx.doi.org/10.1001/jamaneurol.2020.4607

Ejemplares similares